Colorectal cancer patients with high expression levels of CDK 5/10/16 achieved lower OS, while high expression of CDK12 increased OS, hinting that CDK 5/10/12/16 can be utilized as prognostic biomarkers. Here, CDK12 is linked to colorectal cancer.